Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis. (Q41721818)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Interferon-beta affects mitochondrial activity in CD4+ lymphocytes: Implications for mechanism of action in multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bartosz Pula

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Xavier Montalban

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

9

Ralf Gold

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Aiden Haghikia

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Simon Faissner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Derek Pappas

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Denis A Akkad

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Larissa Arning

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sabrina Ruhrmann

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Alexander Duscha

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Sergio E Baranzini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Manuel Comabella

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Andrew Chan

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

5 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1262-1270

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25480861%20AND%20SRC:MED&resulttype=core&format=json

Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-beta1b.

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Longitudinal interferon-β effects in multiple sclerosis: differential regulation of IL-10 and IL-17A, while no sustained effects on IFN-γ, IL-4 or IL-13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Interferon-beta-1b-induced short- and long-term signatures of treatment activity in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

How type I interferons shape myeloid cell function in CNS autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Fuel feeds function: energy metabolism and the T-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Therapies for multiple sclerosis: translational achievements and outstanding needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Functional energetics of CD4+-cellular immunity in monoclonal antibody-associated progressive multifocal leukoencephalopathy in autoimmune disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Localization of sequence variations in PGC-1α influence their modifying effect in Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

The gene coding for PGC-1alpha modifies age at onset in Huntington's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

PGC-1alpha as modifier of onset age in Huntington disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Mitochondrial haplogroup H correlates with ATP levels and age at onset in Huntington disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Characterization of depolarization and repolarization phases of mitochondrial membrane potential fluctuations induced by tetramethylrhodamine methyl ester photoactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Phagocytosis of apoptotic inflammatory cells by microglia and its therapeutic implications: termination of CNS autoimmune inflammation and modulation by interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Genome-wide network analysis reveals the global properties of IFN-beta immediate transcriptional effects in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Diagnostic value of T-cell monitoring assays in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Molecular mechanisms of the anti-inflammatory functions of interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

New lessons about old molecules: how type I interferons shape Th1/Th17-mediated autoimmunity in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Genomic effects of IFN-beta in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Determinants of interferon β efficacy in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Reduced expression of PGC-1α partly underlies mitochondrial changes and correlates with neuronal loss in multiple sclerosis cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

A single nucleotide polymorphism in the coding region of PGC-1α is a male-specific modifier of Huntington disease age-at-onset in a large European cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

PGC-1α is a male-specific disease modifier of human and experimental amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

MRI activity and neutralising antibody as predictors of response to interferon treatment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909

Longitudinal system-based analysis of transcriptional responses to type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514561909